Intec Pharma Ltd Company Profile (NASDAQ:NTEC)

About Intec Pharma Ltd

Intec Pharma Ltd logoIntec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodynamics of various drugs. The Company is focusing on the clinical development program for the Phase III clinical study of the Accordion Pill Carbidopa Levodopa (AP-CDLD), for the treatment of advanced stages Parkinson's disease patients. Its pipeline also comprises The Accordion Pill-Zaleplon, a drug for sleep onset, which is in Phase II clinical program. Furthermore under research is Accordion Pill-Undisclosed Drug for the prevention and treatment of small bowel non-steroidal anti-inflammatory drug (NSAID) induced ulcers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NTEC
  • CUSIP:
Key Metrics:
  • Previous Close: $4.65
  • 50 Day Moving Average: $5.07
  • 200 Day Moving Average: $5.38
  • 52-Week Range: $3.03 - $6.36
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.35
  • P/E Growth: 0.00
  • Market Cap: $51.87M
  • Outstanding Shares: 11,399,000
  • Beta: 1.75
Debt:
  • Current Ratio: 20.09%
  • Quick Ratio: 20.09%
Additional Links:
Companies Related to Intec Pharma Ltd:

Analyst Ratings

Consensus Ratings for Intec Pharma Ltd (NASDAQ:NTEC) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $9.00 (93.55% upside)

Analysts' Ratings History for Intec Pharma Ltd (NASDAQ:NTEC)
Show:
DateFirmActionRatingPrice TargetDetails
4/5/2016Maxim GroupReiterated RatingBuy$9.00View Rating Details
12/16/2015Roth CapitalReiterated RatingBuyView Rating Details
(Data available from 2/28/2015 forward)

Earnings

Earnings History for Intec Pharma Ltd (NASDAQ:NTEC)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Intec Pharma Ltd (NASDAQ:NTEC)
Current Year EPS Consensus Estimate: $-1.23 EPS
Next Year EPS Consensus Estimate: $-1.39 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.34)($0.34)($0.34)
Q2 20161($0.34)($0.34)($0.34)
Q3 20161($0.34)($0.34)($0.34)
Q4 20161($0.35)($0.35)($0.35)
Q1 20171($0.35)($0.35)($0.35)
Q2 20171($0.35)($0.35)($0.35)
Q3 20171($0.31)($0.31)($0.31)
Q4 20171($0.31)($0.31)($0.31)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Intec Pharma Ltd (NASDAQ:NTEC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Intec Pharma Ltd (NASDAQ:NTEC)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Intec Pharma Ltd (NASDAQ:NTEC)
DateHeadline
News IconIntec Pharma ltd NTEC Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300 (NASDAQ:NTEC)
www.bioportfolio.com - February 18 at 6:07 PM
News IconIntec Pharma ltd NTEC Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:NTEC)
www.bioportfolio.com - January 25 at 12:43 AM
News IconInsomnia pipeline landscape and therapeutics development market review h2 2016 – tucson news now data recovery google store (NASDAQ:NTEC)
handyrecovery.in - November 30 at 7:02 PM
streetinsider.com logoIntec Pharma (NTEC) Enters Agreement with Michael J. Fox Foundation to Support Trial Recruitment (NASDAQ:NTEC)
www.streetinsider.com - November 30 at 7:02 PM
finance.yahoo.com logoIntec Pharma Enters into Agreement with the Michael J. Fox Foundation Around Its Phase III Trial Recruitment (NASDAQ:NTEC)
finance.yahoo.com - November 29 at 2:27 PM
marketwatch.com logoInsomnia Pipeline Landscape and Therapeutics Development Market Review H2 2016 (NASDAQ:NTEC)
www.marketwatch.com - November 17 at 6:11 PM
News IconIntec Pharma ltd. (INTP) - Financial and Strategic SWOT Analysis Review - New Market Report (NASDAQ:NTEC)
reports.pr-inside.com - November 17 at 6:11 PM
finance.yahoo.com logoIntec Pharma to Sponsor Investigator Meeting for Pivotal Phase III Study of Accordion Pill Carbidopa/Levodopa in Advanced Parkinson's Disease Patients (NASDAQ:NTEC)
finance.yahoo.com - November 12 at 9:05 AM
finance.yahoo.com logoIntec Pharma to Sponsor Investigator Meeting for Pivotal Phase III Study of Accordion Pill Carbidopa/Levodopa … (NASDAQ:NTEC)
finance.yahoo.com - November 9 at 8:57 AM
seekingalpha.com logoIntec Pharma cuts sample size in late-stage study of lead product candidate by almost 30%; shares up 11% (NASDAQ:NTEC)
seekingalpha.com - November 8 at 9:50 AM
reuters.com logoBRIEF-Intec Pharma makes amendment to advanced parkinson's patient's study (NASDAQ:NTEC)
www.reuters.com - November 7 at 10:21 AM
finance.yahoo.com logoIntec Pharma Announces Protocol Amendment to Phase III Study of Accordion Pill Carbidopa/Levodopa in Advanced Parkinson's Disease Patients (NASDAQ:NTEC)
finance.yahoo.com - November 7 at 10:21 AM
News IconAccordion Pill, Aiming to Bolster Parkinson’s Treatments, Gets Patent in China (NASDAQ:NTEC)
parkinsonsnewstoday.com - November 2 at 6:50 PM
News IconReport of Foreign Issuer (6-k) (NASDAQ:NTEC)
ih.advfn.com - November 2 at 10:03 AM
businesswire.com logoIntec Pharma Granted Chinese Patent for Accordion Pill TM Carbidopa / Levodopa (NASDAQ:NTEC)
www.businesswire.com - October 31 at 1:16 PM
publicnow.com logoIntec Pharma Granted Chinese Patent for Accordion PillTM Carbidopa / Levodopa (NASDAQ:NTEC)
www.publicnow.com - October 31 at 1:16 PM
streetinsider.com logoForm 6-K Intec Pharma Ltd. For: Oct 07 (NASDAQ:NTEC)
www.streetinsider.com - October 7 at 11:35 AM
investing.com logoIntec Pharma: A New Pill Delivering Best-In-Class Results (NASDAQ:NTEC)
www.investing.com - September 29 at 11:38 AM
4-traders.com logoIntec Pharma : NTEC) Gives Up 4.07% at Midday on September 22, Pressuring Health Care Stocks (NASDAQ:NTEC)
www.4-traders.com - September 23 at 6:00 PM
publicnow.com logoIntec Pharma Ltd. (NTEC) Gives Up 4.07% at Midday on September 22, Pressuring Health Care Stocks (NASDAQ:NTEC)
www.publicnow.com - September 23 at 6:00 PM
finance.yahoo.com logoIntec Pharma to Participate in Upcoming September Conferences (NASDAQ:NTEC)
finance.yahoo.com - September 7 at 6:38 PM
finance.yahoo.com logoIntec Pharma Granted European Patent for Accordion Pill™–Carbidopa / Levodopa (NASDAQ:NTEC)
finance.yahoo.com - September 7 at 10:03 AM
publicnow.com logoIntec Pharma Granted European Patent for Accordion Pill(TM)-Carbidopa / Levodopa (NASDAQ:NTEC)
www.publicnow.com - September 6 at 11:12 AM
rttnews.com logoIntec Pharma Posts Wider Loss In Q2 - Quick Facts (NASDAQ:NTEC)
www.rttnews.com - September 2 at 11:20 AM
4-traders.com logoIntec Pharma : net loss widens in Q2; shares up 7% premarket (NASDAQ:NTEC)
www.4-traders.com - September 2 at 11:20 AM
businesswire.com logoIntec Pharma Reports First Half 2016 Financial Results (NASDAQ:NTEC)
www.businesswire.com - September 2 at 11:20 AM
publicnow.com logoIntec Pharma net loss widens in Q2; shares up 7% premarket (NASDAQ:NTEC)
www.publicnow.com - September 1 at 9:39 AM
News IconIntec Pharma begins clinical development of Accordion Pill for cannabinoid therapies (NASDAQ:NTEC)
www.bioportfolio.com - August 7 at 10:41 AM
publicnow.com logoIntec Pharma to Pursue Development of Accordion Pill for Cannabinoid Therapies (NASDAQ:NTEC)
www.publicnow.com - August 4 at 9:41 AM
publicnow.com logoIntec Pharma Ltd. (NTEC) Charges Ahead 8.2%, Just After Opening Bell on August 1 to Bolster Health Care Stocks (NASDAQ:NTEC)
www.publicnow.com - August 2 at 11:23 AM
publicnow.com logoHealth Care Firm Intec Pharma Ltd. (NTEC) Advances 11.52% at Midday on August 1 (NASDAQ:NTEC)
www.publicnow.com - August 2 at 11:23 AM
News IconIndian student warns his countrymen over fraudulent paperwork (NASDAQ:NTEC)
www.tvnz.co.nz - July 2 at 9:18 AM
rttnews.com logoIntec Pharma Names Nir Sassi CFO, Effective Aug. 1, Succeeding Oren Mohar (NASDAQ:NTEC)
www.rttnews.com - June 3 at 9:23 AM
News IconIntec Pharma Announces Planned Management Changes (NASDAQ:NTEC)
www.kait8.com - June 3 at 9:23 AM
publicnow.com logoIntec Pharma Receives Approval for US$5.2 Million Grant (NASDAQ:NTEC)
www.publicnow.com - May 31 at 8:42 AM
nasdaq.com logoIntec Pharma Nominates John Kozarich As Chairman Of Board - Quick Facts (NASDAQ:NTEC)
www.nasdaq.com - May 16 at 1:09 PM
publicnow.com logoIntec Pharma to Nominate Dr. John W. Kozarich as Chairman of the Board of Directors (NASDAQ:NTEC)
www.publicnow.com - May 16 at 8:42 AM
publicnow.com logoIntec Pharma Appoints VP of Clinical and Regulatory Affairs (NASDAQ:NTEC)
www.publicnow.com - May 3 at 8:10 AM
publicnow.com logoIntec Pharma Enrolls First Patient in Pivotal Phase III Clinical Trial of AP-CDLD for Advanced Parkinson’s Disease Patients (NASDAQ:NTEC)
www.publicnow.com - April 11 at 4:07 AM
publicnow.com logoIntec Pharma Expands Intellectual Property for AP-CDLD with Patent in South Korea (NASDAQ:NTEC)
www.publicnow.com - April 6 at 8:10 AM
rttnews.com logoCYTR Awaits Data In June, GILD Gets FDA Nod, PGNX Will Have To Wait (NASDAQ:NTEC)
www.rttnews.com - April 5 at 11:54 AM
publicnow.com logoIntec Pharma Enrolls First Patient in Pivotal Phase III Clinical Trial of AP-CDLD for Advanced Parkinson's Disease Patients (NASDAQ:NTEC)
www.publicnow.com - April 4 at 8:07 AM
4-traders.com logoIntec Pharma : Mr. Zvika Joseph to Step Down as Chairman of the Board of Directors (NASDAQ:NTEC)
www.4-traders.com - March 19 at 11:19 AM
finance.yahoo.com logoINTEC PHARMA LTD. Financials (NASDAQ:NTEC)
finance.yahoo.com - March 17 at 1:04 PM
finance.yahoo.com logoMr. Zvika Joseph to Step Down as Chairman of the Board of Directors (NASDAQ:NTEC)
finance.yahoo.com - March 17 at 10:30 AM
finance.yahoo.com logoIntec Pharma Reports 2015 Fourth Quarter and Full-Year Financial Results (NASDAQ:NTEC)
finance.yahoo.com - March 14 at 7:45 AM
finance.yahoo.com logoIntec Pharma Ltd. Announces Availability of Its Annual Report on Form 20-F Through Its Website (NASDAQ:NTEC)
finance.yahoo.com - March 14 at 7:30 AM
finance.yahoo.com logoIntec Pharma Ltd.: Notice of Special General Meeting of Shareholders (NASDAQ:NTEC)
finance.yahoo.com - March 14 at 7:15 AM
fxpips.com logoActive Stocks Climbing Strong – PULM, HTGM, SHIP, NTEC, SYX, DWCH, BPI (NASDAQ:NTEC)
www.fxpips.com - March 10 at 11:22 AM
finance.yahoo.com logo8:11 am Intec Pharma completes Phase 1 clinical trial with third pipeline product (NASDAQ:NTEC)
finance.yahoo.com - March 10 at 8:11 AM

Social

What is Intec Pharma Ltd's stock symbol?

Intec Pharma Ltd trades on the NASDAQ under the ticker symbol "NTEC."

Where is Intec Pharma Ltd's stock going? Where will Intec Pharma Ltd's stock price be in 2017?

1 analysts have issued 12 month price targets for Intec Pharma Ltd's stock. Their forecasts range from $9.00 to $9.00. On average, they anticipate Intec Pharma Ltd's share price to reach $9.00 in the next year.

How do I buy Intec Pharma Ltd stock?

Shares of Intec Pharma Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Intec Pharma Ltd stock cost?

One share of Intec Pharma Ltd stock can currently be purchased for approximately $4.65.

Intec Pharma Ltd (NASDAQ:NTEC) Chart for Tuesday, February, 28, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Intec Pharma Ltd (NASDAQ:NTEC)

Earnings History Chart

Earnings by Quarter for Intec Pharma Ltd (NASDAQ:NTEC)

Dividend History Chart

Dividend Payments by Quarter for Intec Pharma Ltd (NASDAQ:NTEC)

Last Updated on 2/28/2017 by MarketBeat.com Staff